欧洲药品管理局建议撤销安进公司一款罕见病药物的上市许可

路透中文
Jun 26
欧洲药品管理局建议撤销<a href="https://laohu8.com/S/AMGN">安进</a>公司一款罕见病药物的上市许可

路透6月26日 - 欧洲药品管理局周五建议撤销安进公司(Amgen)用于治疗 AMGN.O 罕见病的药物Tavneos的市场授权。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10